Karyopharm Therapeutics, Inc. (KPTI)
1.87
-0.09
(-4.59%)
USD |
NASDAQ |
Aug 24, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap : 42.41M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 44.45M |
| August 20, 2026 | 41.28M |
| August 19, 2026 | 45.36M |
| August 18, 2026 | 43.77M |
| August 17, 2026 | 41.05M |
| August 14, 2026 | 45.81M |
| August 13, 2026 | 45.13M |
| August 12, 2026 | 46.04M |
| August 11, 2026 | 47.63M |
| August 10, 2026 | 44.45M |
| August 07, 2026 | 47.79M |
| August 06, 2026 | 43.96M |
| August 05, 2026 | 43.06M |
| August 04, 2026 | 44.19M |
| August 03, 2026 | 44.41M |
| July 31, 2026 | 43.28M |
| July 30, 2026 | 158.03M |
| July 29, 2026 | 154.65M |
| July 28, 2026 | 159.84M |
| July 27, 2026 | 159.84M |
| July 24, 2026 | 167.05M |
| July 23, 2026 | 159.84M |
| July 22, 2026 | 161.87M |
| July 21, 2026 | 177.31M |
| July 20, 2026 | 168.40M |
| Date | Value |
|---|---|
| July 17, 2026 | 214.39M |
| July 16, 2026 | 211.46M |
| July 15, 2026 | 214.84M |
| July 14, 2026 | 225.67M |
| July 13, 2026 | 226.57M |
| July 10, 2026 | 233.10M |
| July 09, 2026 | 229.95M |
| July 08, 2026 | 240.54M |
| July 07, 2026 | 226.57M |
| July 06, 2026 | 216.87M |
| July 02, 2026 | 216.42M |
| July 01, 2026 | 215.30M |
| June 30, 2026 | 220.25M |
| June 29, 2026 | 227.36M |
| June 26, 2026 | 230.17M |
| June 25, 2026 | 213.27M |
| June 24, 2026 | 205.60M |
| June 23, 2026 | 217.55M |
| June 22, 2026 | 202.90M |
| June 18, 2026 | 203.35M |
| June 17, 2026 | 211.91M |
| June 16, 2026 | 205.15M |
| June 15, 2026 | 217.32M |
| June 12, 2026 | 214.17M |
| June 11, 2026 | 202.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 11.82B |
| Relay Therapeutics, Inc. | 4.318B |
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
| Anika Therapeutics, Inc. | 285.19M |
Market Cap Related Metrics
| PS Ratio | 0.2558 |
| PEG Ratio | -0.0076 |
| Price | 1.87 |
| Earnings Yield | -699.6% |
| PEGY Ratio | -0.0076 |